Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


A pilot study of hot-wire, ultrasonic and wedge-bellows spirometer inter- and intra-variability.

Aardal ME, Svendsen LL, Lehmann S, Eagan TM, Haaland I.

BMC Res Notes. 2017 Oct 10;10(1):497. doi: 10.1186/s13104-017-2825-0.


Protected sampling is preferable in bronchoscopic studies of the airway microbiome.

Grønseth R, Drengenes C, Wiker HG, Tangedal S, Xue Y, Husebø GR, Svanes Ø, Lehmann S, Aardal M, Hoang T, Kalananthan T, Hjellestad Martinsen EM, Orvedal Leiten E, Aanerud M, Nordeide E, Haaland I, Jonassen I, Bakke P, Eagan T.

ERJ Open Res. 2017 Aug 30;3(3). pii: 00019-2017. doi: 10.1183/23120541.00019-2017. eCollection 2017 Jul.


Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia.

Haaland I, Opsahl JA, Berven FS, Reikvam H, Fredly HK, Haugse R, Thiede B, McCormack E, Lain S, Bruserud O, Gjertsen BT.

Mol Cancer. 2014 May 21;13:116. doi: 10.1186/1476-4598-13-116.


The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences.

Grønseth R, Haaland I, Wiker HG, Martinsen EM, Leiten EO, Husebø G, Svanes Ø, Bakke PS, Eagan TM.

Eur Clin Respir J. 2014 Dec 29;1. doi: 10.3402/ecrj.v1.26196. eCollection 2014.


cAMP signalling inhibits p53 acetylation and apoptosis via HDAC and SIRT deacetylases.

Kloster MM, Naderi EH, Haaland I, Gjertsen BT, Blomhoff HK, Naderi S.

Int J Oncol. 2013 May;42(5):1815-21. doi: 10.3892/ijo.2013.1853. Epub 2013 Mar 8.


Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia.

McCormack E, Haaland I, Venås G, Forthun RB, Huseby S, Gausdal G, Knappskog S, Micklem DR, Lorens JB, Bruserud O, Gjertsen BT.

Leukemia. 2012 May;26(5):910-7. doi: 10.1038/leu.2011.315. Epub 2011 Nov 8.


Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.

Ånensen N, Hjelle SM, Van Belle W, Haaland I, Silden E, Bourdon JC, Hovland R, Taskén K, Knappskog S, Lønning PE, Bruserud Ø, Gjertsen BT.

Oncogene. 2012 Mar 22;31(12):1533-45. doi: 10.1038/onc.2011.348. Epub 2011 Aug 22.


Clinical proteomics of myeloid leukemia.

Hjelle SM, Forthun RB, Haaland I, Reikvam H, Sjøholt G, Bruserud O, Gjertsen BT.

Genome Med. 2010 Jun 29;2(6):41. doi: 10.1186/gm162.


Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.

Wergeland L, Sjøholt G, Haaland I, Hovland R, Bruserud Ø, Gjertsen BT.

Mol Cancer. 2007 May 11;6:33.


Expert assessment of exposure to carcinogens in Norway's offshore petroleum industry.

Steinsvåg K, Bråtveit M, Moen B, Austgulen LV, Hollund BE, Haaland IM, Naerheim J, Svendsen K, Kromhout H.

J Expo Sci Environ Epidemiol. 2008 Mar;18(2):175-82. Epub 2007 Apr 25.


Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia.

Anensen N, Haaland I, D'Santos C, Van Belle W, Gjertsen BT.

Curr Pharm Biotechnol. 2006 Jun;7(3):199-207. Review.


Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables.

Van Belle W, Anensen N, Haaland I, Bruserud Ø, Høgda KA, Gjertsen BT.

BMC Bioinformatics. 2006 Apr 10;7:198.


Exposure to sulfuric acid in zinc production.

Bråtveit M, Haaland IM, Moen BE, Målsnes A.

Ann Occup Hyg. 2004 Mar;48(2):159-70.


Supplemental Content

Loading ...
Support Center